These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 132208)

  • 21. Activation of bovine factor XII (Hageman factor) by plasma kallikrein.
    Fujikawa K; Heimark RL; Kurachi K; Davie EW
    Biochemistry; 1980 Apr; 19(7):1322-30. PubMed ID: 6155941
    [No Abstract]   [Full Text] [Related]  

  • 22. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanism of activation of kallikrein-kinin system in the plasma of patients with atopic allergic diseases].
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1988; 34(6):89-94. PubMed ID: 3238945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [General mechanisms of biochemical regulation of the kallikrein, clotting and fibrinolytic systems of the blood].
    Gomazkov OA; Komissarova NV
    Usp Sovrem Biol; 1976; 82(6):356-70. PubMed ID: 65846
    [No Abstract]   [Full Text] [Related]  

  • 27. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional relations between blood clotting, fibrinolysis and kinin-forming systems of blood.
    Buluk K; Czokalo M; Malofiejew M
    Pol Med J; 1971; 10(3):611-8. PubMed ID: 4108022
    [No Abstract]   [Full Text] [Related]  

  • 29. Cold promoted activation of Factor VII. V. Relation to the fibrinolytic system.
    Gjonnaess H
    Thromb Diath Haemorrh; 1973 Feb; 29(1):143-53. PubMed ID: 4267736
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelations between the clotting and kinin systems. Activation of factor VII involving prekallikrein-kallikrein. A review.
    Stormorken H; Gjoennaess H; Laake K
    Haemostasis; 1973-1974; 2(6):245-52. PubMed ID: 4278152
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the kallikrein-kinin system of the blood during development of experimental myocardial infarct].
    Frol'kis RA; Gunina LM
    Vopr Med Khim; 1978; 24(6):747-53. PubMed ID: 734974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence.
    Clark CC; Hofman ZLM; Sanrattana W; den Braven L; de Maat S; Maas C
    Thromb Haemost; 2020 Mar; 120(3):400-411. PubMed ID: 31940673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New data on kallikrein in rabbit serum].
    Paskhina TS; Zykova VP
    Dokl Akad Nauk SSSR; 1967 Apr; 173(6):1451-4. PubMed ID: 5623167
    [No Abstract]   [Full Text] [Related]  

  • 37. Streptokinase-induced activation of the kallikrein-kinin system and of the contact phase in patients with acute myocardial infarction.
    Hoffmeister HM; Ruf M; Wendel HP; Heller W; Seipel L
    J Cardiovasc Pharmacol; 1998 May; 31(5):764-72. PubMed ID: 9593077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma kallikrein and plasmin as activators of prorenin: links between the renin-angiotensin system and other proteolytic systems in plasma.
    Schalekamp MA; Derkx FH
    Clin Sci (Lond); 1981 Jul; 61(1):15-21. PubMed ID: 6454526
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.
    Colman RW; Mason JW; Sherry S
    Ann Intern Med; 1969 Oct; 71(4):763-73. PubMed ID: 5360288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.